Tokyo Tape
Sign in
← Terumo

Quarterly report · Q1

4543.TEDINET S100OZIL
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥197.3bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥703.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥171.7bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥30.4bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥36.2bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥29.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥114.5bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥36.0bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥88.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥27.9bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥27.9bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥1.58Tat 2022-06-30Cons.Assets IFRS
Total assets¥1.47Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.34Tat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥466.9bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥461.4bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.12Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.01Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥874.0bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥856.7bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.12Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.01Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥874.0bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥209.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥186.7bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥200.8bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥23.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥141.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥29.9bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥16.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥78.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥21.0bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.8bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥70.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥23.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥29.612022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥117.452021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥36.92021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥29.62022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥117.382021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥36.872021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio70.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio68.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio65.2%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥62m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥198m
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥34.5bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥116.8bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥28.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥46.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.5bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥197.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥36.1bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-06-30¥64m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥1.6bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2021-04-01 → 2021-06-30¥28.3bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.0bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2021-04-01 → 2021-06-30¥99.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2021-04-01 → 2021-06-30¥29.4bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2021-04-01 → 2021-06-30¥43.8bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.4bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥171.7bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥41.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 562
ItemContextValueUnit
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember51829000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-6838000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember775078000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember-2123000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember856662000000JPY
Equity IFRSPrior2YearInstant856662000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember27895000000JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember27895000000JPY
Profit loss IFRSPrior1YTDDuration27895000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember696000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember696000000JPY
Other comprehensive income IFRSPrior1YTDDuration696000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember27895000000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember696000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember28592000000JPY
Comprehensive income IFRSPrior1YTDDuration28592000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-0JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-0JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration-0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember23000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-1000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-21000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration0JPY
Dividends ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-11340000000JPY
Dividends ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-11340000000JPY
Dividends ss IFRSPrior1YTDDuration-11340000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember50000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass